You donate – CytoSorbents doubles your donation
Help is needed right now! Millions of people around the globe are being adversely affected by the novel coronavirus. CytoSorbents has thus initiated a global donation campaign to support CARE in helping those who need it the most during this pandemic.
CARE is an international aid organization that in response to the COVID-19 pandemic, has launched one of the largest emergency response efforts in their 75-year history to help stop the spread.
Join us and donate! CytoSorbents doubles your donation up to a total amount of $100,000. The raised money will go to CARE´s COVID-19 Emergency Fund.
of the donation amount has already been reached
Examples of how we can support CARE together
Thanks to your donation, CARE can help those affected around the world to deal with the dangers of COVID-19. As an international aid organization, CARE has already established corona emergency aid plans in 69 countries. With your support, we can achieve a lot more together.
We must act now
Please support CARE emergency response to the COVID-19 pandemic. Every donation helps stop the spread of COVID-19 and build back a better, safer future for women, girls and their communities. See here how CARE can help.
Share our mission with your colleagues:
Here we would like to answer frequently asked questions about the fundraising campaign. You can find more background information and details about the work of CARE and about CytoSorbents and CytoSorb therapy through these links:
Every incoming donation is doubled by CytoSorbents with an amount of up to $50,000, so that the donation goal is reached more quickly.
The fundraising campaign is international and people from all over the world can participate. For tax reasons, donors from the USA and Germany have their own donation button and donation channel (“International” and “German”). Donors from all other countries can use the other donation button “International”. Donors from the USA and Germany will automatically receive a donation receipt recognized by the tax office from CARE in early 2021. Donors from other countries receive a donation receipt, which is not necessarily recognized by every tax office.
For international donations please select as State/Province “None” in the dropdown.
CARE is a globally active organization that has been fighting against hardship, poverty and injustice around the globe for 75 years.
In response to COVID-19, CARE is doing humanitarian work, especially in crisis areas, and meeting the urgent needs of more than 100 million people. These include: equipping households and healthcare facilities with hygiene items such as soap and disinfectants. Disseminating accurate prevention information to educate people. Installation of hand washing stations in schools, markets and other public places. Provision of clean water through emergency water transport and distribution of storage containers for safe water. Addressing food shortages and other economic effects of pandemic lockdowns.
The collected donations go directly and 100% to CARE and are used there for CARE’s worldwide COVID-19 emergency response. In particular, these are health and hygiene programs to prevent and contain COVID-19 in order to alleviate the effects of the pandemic. And that directly on site: The CARE state employees – most of whom come from the communities in which they live and work – have the close relationships and trust that are necessary to get people to act. Many CARE country teams have experienced employees who are familiar with dealing with epidemics such as cholera, Ebola and Zika.
Formal and expert recommendations for CytoSorb Therapy are in place in many countries. The FDA in USA granted CytoSorb Therapy Emergency Use Authorization for use in critically-ill COVID-19 patients with imminent or confirmed respiratory failure.
CytoSorb Therapy reduces inflammatory mediators in the blood and targets the underlying pathophysiology in critically-ill COVID-19 patients. Hyperinflammation (often referred to as cytokine storm) may be a key component in many critically-ill COVID-19 patients and controlling the inflammatory response may be as important as targeting the virus.